Pharmacological activities of glial cell line-derived neurotrophic factor (GDNF): preclinical development and application to the treatment of Parkinson's disease.
Lapchak
P A
PA
Department of Neuroscience, AMGEN Inc., Thousand Oaks, California 91320, USA. darcatz@aol.com
Gash
D M
DM
Collins
F
F
Hilt
D
D
Miller
P J
PJ
Araujo
D M
DM
D000818:Animals; D002460:Cell Line; D051100:Glial Cell Line-Derived Neurotrophic Factor; D006801:Humans; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins / Q000627:therapeutic use*; D009457:Neuroglia / Q000737:chemistry / Q000166:cytology; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*
C495039:GDNF protein, human; D051100:Glial Cell Line-Derived Neurotrophic Factor; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; D018696:Neuroprotective Agents